CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer.

Jiahui SiPanpan ZhangDan TianXing WangYuanyuan MaJianzhi ZhangLu WangYue Yang

Published in: World journal of surgical oncology (2017)

CMTM1_v17 expression is significantly associated with chemoresistance and poor prognosis of the early stage NSCLC patients who have received NAC.

Keyphrases